CSS LLC’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$426K 1007
2022
Q3
$426K Sell
10,000
-41,200
-80% -$2.11M 0.02% 564
2022
Q2
$2.86M Buy
51,200
+5,700
+13% +$338K 0.12% 209
2022
Q1
$2.82M Buy
45,500
+34,500
+314% +$2.11M 0.1% 201
2021
Q4
$607K Buy
11,000
+6,000
+120% +$313K 0.02% 584
2021
Q3
$263K Sell
5,000
-49,800
-91% -$2.96M 0.01% 822
2021
Q2
$3.77M Buy
54,800
+19,000
+53% +$1.45M 0.16% 129
2021
Q1
$2.76M Buy
+35,800
New +$3.3M 0.11% 170

Other funds holding LKFT

CSS LLC's LKFT Position: Q4 2022 in Review

CSS LLC sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2022, closing a stake of 599 shares — an estimated $26K sold.

CSS LLC first reported a position in LKFT in Q3 2021 and held it in 3 quarters. The position peaked at $411K in Q4 2021. 75 funds tracked by Wall St. Rank hold LKFT as of Q4 2022.

  • CSS LLC reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 599 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2022, an estimated $26K.
  • CSS LLC first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • CSS LLC's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.